Showing results (421-430 of 458) with videos related to

Sort By:
Pageof 46
Critical Reviews in Oncology/Hematology|June 21, 2015
Prostate Cancer Unit Initiative in Europe: A position paper by the European School of OncologyRiccardo Valdagni, Hendrik Van Poppel, Michael Aitchison, et al.
The New England Journal of Medicine|September 18, 2020
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThomas Powles, Se Hoon Park, Eric Voog, et al.
Communications Medicine|January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohortMajd Al Assaad, Kevin Hadi, Max F Levine, et al.
JCO Precision Oncology|September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort AnalysisAnuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
The Lancet. Oncology|January 21, 2015
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 studyCharles J Ryan, Matthew R Smith, Karim Fizazi, et al.
The New England Journal of Medicine|June 3, 2014
Enzalutamide in metastatic prostate cancer before chemotherapyTomasz M Beer, Andrew J Armstrong, Dana E Rathkopf, et al.
Clinical Genitourinary Cancer|May 14, 2018
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access ProgramGiuseppe Procopio, Michele Prisciandaro, Roberto Iacovelli, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
The New England Journal of Medicine|May 27, 2011
Abiraterone and increased survival in metastatic prostate cancerJohann S de Bono, Christopher J Logothetis, Arturo Molina, et al.
Pageof 46